A Win For FibroGen, Inc.

Mon, Jan 29, 2024 at 07:16 PM
A Win For FibroGen, Inc.

FibroGen, Inc. (FGEN:NASDAQ) jumped higher at $1.71, a gain of 82.7%. On Mon, Jan 29, 2024, FGEN:NASDAQ hit a New 2-Week High of $1.71. The stock appeared on our News Catalysts scanner on Thu, Jan 25, 2024 at 07:53 AM in the 'BIOTECH' category. From Tue, Jan 16, 2024, the stock recorded 66.67% Up Days and 80.00% Green Days

About FibroGen, Inc. (FGEN:NASDAQ)

FibroGen Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of novel therapeutics to treat serious unmet medical needs.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.